ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
17K |
6.6M |
39 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
17K
|
6.6M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
9.6K |
2.8M |
30 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
9.6K |
2.8M |
38 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
38
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
184 |
65K |
29 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
184
|
65K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
Phaedrus
|
518 |
162K |
37 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
518
|
162K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
184 |
65K |
28 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
184
|
65K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Phaedrus
|
474 |
154K |
12 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
474
|
154K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
184 |
65K |
31 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
184
|
65K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
184 |
65K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
184
|
65K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
184 |
65K |
11 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
184
|
65K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
184 |
65K |
16 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
184
|
65K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
9.6K |
2.8M |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Phaedrus
|
193 |
65K |
26 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
193
|
65K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Phaedrus
|
193 |
65K |
14 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
193
|
65K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Phaedrus
|
474 |
154K |
12 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
474
|
154K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Phaedrus
|
474 |
154K |
20 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
474
|
154K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Chair Transition
|
|
Phaedrus
|
18 |
7.3K |
26 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
7.3K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Phaedrus
|
1.1K |
342K |
33 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
1.1K
|
342K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
Phaedrus
|
89 |
46K |
15 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
89
|
46K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
Phaedrus
|
89 |
46K |
11 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
89
|
46K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
Phaedrus
|
89 |
46K |
18 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
89
|
46K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
Phaedrus
|
89 |
46K |
20 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
89
|
46K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
Phaedrus
|
89 |
46K |
29 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
89
|
46K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Phaedrus
|
556 |
228K |
25 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
556
|
228K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
17K |
6.6M |
36 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Phaedrus
|
273 |
118K |
19 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
273
|
118K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Jane Bell
|
|
Phaedrus
|
38 |
18K |
26 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
38
|
18K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
46K |
20 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
46K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
46K |
55 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
46K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
46K |
15 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
46K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
46K |
45 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
46K
|
45
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
601 |
233K |
5 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
601
|
233K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
601 |
233K |
14 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
601
|
233K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
601 |
233K |
16 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
601
|
233K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
601 |
233K |
36 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
601
|
233K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
9.6K |
2.8M |
8 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Newsflow & Re-rate Estimations
|
|
Phaedrus
|
52 |
23K |
53 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
52
|
23K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Phaedrus
|
116 |
42K |
21 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
42K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Phaedrus
|
556 |
228K |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
556
|
228K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Phaedrus
|
556 |
228K |
19 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
556
|
228K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Phaedrus
|
556 |
228K |
3 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
556
|
228K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
17K |
6.6M |
7 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
17K
|
6.6M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Phaedrus
|
5.2K |
2.5M |
4 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5.2K
|
2.5M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Phaedrus
|
272 |
100K |
36 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
272
|
100K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Phaedrus
|
272 |
100K |
14 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
272
|
100K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Phaedrus
|
272 |
100K |
37 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
272
|
100K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
601 |
233K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
601
|
233K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
601 |
233K |
9 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
601
|
233K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Phaedrus
|
551 |
203K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
203K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Phaedrus
|
551 |
203K |
46 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
203K
|
46
|
|